172 related articles for article (PubMed ID: 12547996)
1. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
2. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
3. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
[TBL] [Abstract][Full Text] [Related]
5. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
Saito T; Fujii K; Takizawa T; Toyosaki T; Kuwabara Y; Kobayashi S; Ichikawa H; Karaki A; Yamazaki Y; Iwata J; Yamada K; Tomiya H; Takeda K; Inagaki Y
Arzneimittelforschung; 1996 Sep; 46(9):861-7. PubMed ID: 8876934
[TBL] [Abstract][Full Text] [Related]
6. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
7. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
8. Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.
Nada T; Nomura M; Koshiba K; Kawano T; Mikawa J; Ito S
Arzneimittelforschung; 2007; 57(11):698-704. PubMed ID: 18193691
[TBL] [Abstract][Full Text] [Related]
9. Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation as demonstrated by iodine-123 metaiodobenzylguanidine imaging in rat hearts.
Sakaki T; Naruse H; Masai M; Takahashi K; Ohyanagi M; Iwasaki T; Fukuchi M
Ann Nucl Med; 2003 Jun; 17(4):321-6. PubMed ID: 12932117
[TBL] [Abstract][Full Text] [Related]
10. The Ca(2+) channel inhibitor efonidipine decreases voltage-dependent K(+) channel activity in rabbit coronary arterial smooth muscle cells.
Park MH; Son YK; Hong DH; Choi IW; Kim DJ; Lee H; Bang H; Na SH; Li H; Jo SH; Park WS
Vascul Pharmacol; 2013; 59(3-4):90-5. PubMed ID: 23876554
[TBL] [Abstract][Full Text] [Related]
11. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for efonidipine block of a voltage-gated Ca
Xu F; Xiong W; Huang Y; Shen J; Zhou D; Tang L
Biochem Biophys Res Commun; 2019 Jun; 513(3):631-634. PubMed ID: 30981510
[TBL] [Abstract][Full Text] [Related]
13. Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs.
Yokoyama T; Ichihara K; Abiko Y
Jpn J Pharmacol; 1996 Dec; 72(4):291-7. PubMed ID: 9015737
[TBL] [Abstract][Full Text] [Related]
14. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
[TBL] [Abstract][Full Text] [Related]
15. A selective T-type Ca2+ channel blocker R(-) efonidipine.
Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
Masumiya H; Shijuku T; Tanaka H; Shigenobu K
Eur J Pharmacol; 1998 May; 349(2-3):351-7. PubMed ID: 9671117
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
[TBL] [Abstract][Full Text] [Related]
18. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Nawada R; Obayashi K; Togi K; Miho N
Hypertension; 1999 Jun; 33(6):1447-52. PubMed ID: 10373231
[TBL] [Abstract][Full Text] [Related]
19. [Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
Yokoyama T; Fujikura N; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):307-21. PubMed ID: 9017685
[TBL] [Abstract][Full Text] [Related]
20. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]